US$ 21.57
glutathione and statins ameliorate oxaliplatin- paclitaxel-induced peripheral neuropathy via S-transferase Glutathione system enhancement for cardiac
Description
SURMOUNT-MAINTAIN (Horn 2026, 112 weeks): continued top dose -21.9% vs 5 mg step-down -16.6% vs placebo -9.9%, rescue therapy 8/25/67%: Aronne JAMA 2024

Hunt, M

Shen, Y., Huang, Q., Zhang, Y., Hsueh, C.-Y

Bottom Line on Dosing Finding your "sweet spot" with glutathione is a journey of listening to your body and understanding your goals
